Citoprotective effects of erythropoietin.

2009№1

Yu. M. Zakharov (Chelyabinsk)
Chelyabinsk State Medical Academy

This state-of-art lecture is dedicated to erythropoietin influence on not hemopoietic tissues, the opportunity of this mediator to decrease the expression of tissue damage at experimental hypoxia and ischemia.

erythropoietin

erythropoietin receptors

ischemia

apoptosis

ischemic preconditioning

Full text (in Russian)

Citoprotective effects of erythropoietin.

Yu. M. Zakharov (Chelyabinsk)

Keywords

Similar Articles

Similar Articles

№2 / 2011
A.Yu. Zemchenkov, K.A.Vishnevsky, R.P.Gerasimchuk, S.L.Gavric, T.G.Kostyleva, V.N.Suchkov
The efficacy and safety evaluation of the domestic erythropoietin-β. The review and open multicenter study report

№1 / 2015
N.A. Makarova, Ju.M. Zaharov
Relationship of renal excretory function impairment to serum erythropoietin level in chronic heart failure

№4 / 2024
Popov S.V., Guseinov R.G., Yesayan A.M., Isakova-Sivak I.N., Sivak K.V., Skryabin O.N., Gorbacheva I.A., Matveeva D.A., Grushevsky R.O., Kovalevskaya A.V., Beshtoev A.Kh., Malyshev E.A., Lelyavina T.A.
Biological significance of differentially expressed genes of hypoxic-ischemic acute kidney injury (part 2)

№1 / 2011
P.A. Vorobev, L.J. Bezmelnitsyna
Epidemiology and quality of life in patients with chronic renal failire and anemia, receiving programm hemodyalisis. Part 1. Epidemiology and use of erythropoietin medications

№3 / 2009
Hasabov N.N.
Use of erythropoietin in patients with terminal renal failure, treated with chronic hemodialysis (results of multicenter observational studs)